bendamustina medac
medac gesellschaft fur klinische spezialpraparate mbh - bendamustina - bendamustina
calquence
astrazeneca ab - acalabrutinib - leucemia, linfocitica, cronica, b-cell - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
bendamustina aurobindo
eugia pharma (malta) limited - bendamustina - bendamustina
mabcampath
genzyme europe b.v. - alemtuzumab - leucemia, linfocitica, cronica, b-cell - agenti antineoplastici - mabcampath è indicato per il trattamento dei pazienti con la leucemia linfocitaria cronica della b-cellula (bcll) per i quali la chemioterapia di combinazione con fludarabina non è appropriata.
vaqta
msd italia s.r.l. - vaccino dell'epatite a, inattivato, virus intero - vaccino dell'epatite a, inattivato, virus intero
bendamustina accord
accord healthcare, s.l.u. - bendamustina - bendamustina
bendamustina eg
eg s.p.a. - bendamustina - bendamustina
bendamustina sandoz
sandoz s.p.a. - bendamustina - bendamustina
nivobral
helm ag - bendamustina - bendamustina
bendamustina dr. reddy's
dr. reddy's s.r.l. - bendamustina - bendamustina